ICD-10 · PDGM grouping
D61 Other aplastic anemias and other bone marrow failure syndromes
All 13 codes in the D61 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
13
Can lead a claim
13
Cannot lead a claim
0
What CMS assigns to D61
All 13 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. All 13 count toward the Hemolytic, Aplastic, and Other Anemias comorbidity subgroup. Every code can lead a claim. CMS attaches a code-first note to 1 of the 13.
- Hemolytic, Aplastic, and Other Anemias: can award the low comorbidity tier as a secondary diagnosis.
Code first
CMS grouper convention 8, on D61.2. Code first:
- , if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
Every code in D61
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| D61.0 Constitutional aplastic anemia | ||||
| D61.01 | Constitutional (pure) red blood cell aplasia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.02 | Shwachman-Diamond syndrome | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.03 | Fanconi anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.09 | Other constitutional aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.1 | Drug-induced aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.2 | Aplastic anemia due to other external agents | Can lead a claim, code first applies | K | Hemolytic, Aplastic, and Other Anemias |
| D61.3 | Idiopathic aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.8 Other specified aplastic anemias and other bone marrow failure syndromes | ||||
| D61.81 Pancytopenia | ||||
| D61.810 | Antineoplastic chemotherapy induced pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.811 | Other drug-induced pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.818 | Other pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.82 | Myelophthisis | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.89 | Other specified aplastic anemias and other bone marrow failure syndromesCMS: Oth aplastic anemias and other bone marrow failure syndromes | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.9 | Aplastic anemia, unspecified | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue